ND3- COST-EFFECTIVENESS OF CABERGOLINE COMPARED TO LEVODOPA IN EARLY PARKINSONS DISEASE IN SWEDEN
Sep 1, 2001, 00:00
10.1016/S1098-3015(11)71528-5
https://www.valueinhealthjournal.com/article/S1098-3015(11)71528-5/fulltext
Title :
ND3- COST-EFFECTIVENESS OF CABERGOLINE COMPARED TO LEVODOPA IN EARLY PARKINSONS DISEASE IN SWEDEN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71528-5&doi=10.1016/S1098-3015(11)71528-5
First page :
Section Title :
Open access? :
No
Section Order :
41